What You Won't See in the Media Coverage of a New Weight-Loss Drug

September 16, 2014 4:35 PM

8 0

What You Won't See in the Media Coverage of a New Weight-Loss Drug

This week, the U.S. Food and Drug Administration made headlines for its approval of another obesity drug. News outlets worked hard to translate the meaning of this story, but they left out something important: heads.

After facing public backlash over the withdrawal fen-phen in 1997, the FDA exercised caution towards all subsequent obesity drugs, notably rejecting phentermine/topiramate, lorcaserin, and naltrexone/bupropion in 2010 and 2011. By 2012, the FDA approved the former two after seeing additional safety ...

Read more

To category page

Loading...